menu search

There's a silver lining in pfizer's dark cloud. should you buy the stock?

Pfizer reported an adjusted loss of nearly $1 billion in the third quarter, and recently lowered its fo...

November 3, 2023, 5:30 am

Should you still buy the nasdaq's best-performing october stocks?

Structure Therapeutics' weight-loss drug candidate is attracting attention over excitement about obesity treatments. ImmunityBio rallied on hopes that...

November 3, 2023, 5:20 am

Gold prices steady before nonfarm payrolls, weekly losses on tap

Investing.com– Gold prices steadied on Friday as traders hunkered down before key nonfarm payrolls data, with the yellow metal headed for a weekly...

November 3, 2023, 5:14 am

Warner bros. discovery: undervalued against peers as earnings are poised to rise

WBD continues to show net loss since the merger, but this scenario will soon change. It is generating F...

November 3, 2023, 4:39 am

Oil prices forecast: lower for second week amid middle east, china concerns

Crude oil prices steady, but risk of second weekly loss due to Middle East supply disruptions, China de...

November 3, 2023, 3:21 am

Aud/usd trades with modest intraday losses, hold above 0.6400 as traders keenly await us nfp

The AUD/USD pair extends the previous day’s late pullback from the 0.6455 area, or over a one-month high and remains under some selling pressure thr...

November 3, 2023, 1:44 am

Rosen, leading trial attorneys, encourages docgo inc. investors with losses to secure counsel before important deadline in securities class action – dcgo

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...

November 3, 2023, 12:42 am

Clx loss alert: rosen, a leading law firm, encourages the clorox company investors to inquire about securities class action investigation – clx

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

November 3, 2023, 12:00 am

Sam bankman-fried's found guilty of defrauding ftx customers

The jury in FTX Founder Sam Bankman-Fried's trial has reached a verdict. Found guilty of defrauding FTX customers by jury in New YorkFound guilty on a...

November 2, 2023, 11:48 pm

Bitcoin miner northern data could float cloud unit, expects loss

Northern Data AG could float its cloud computing unit Taiga, the German bitcoin miner said Thursday as it unveiled a debt financing package to buy mor...

November 2, 2023, 9:14 pm

Oil prices steady, on track for second straight week of losses

Oil prices were little changed on Friday, heading for their second straight week of losses as the U.S. ...

November 2, 2023, 8:27 pm

Nl reports third quarter 2023 results

Dallas, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss...

November 2, 2023, 8:20 pm

Puma biotech (pbyi) tops q3 earnings estimates

Puma Biotech (PBYI) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to...

November 2, 2023, 7:32 pm

Mbia (mbi) reports q3 loss, tops revenue estimates

MBIA (MBI) came out with a quarterly loss of $2.92 per share versus the Zacks Consensus Estimate of a...

November 2, 2023, 7:32 pm

Udemy, inc. (udmy) q3 earnings and revenues top estimates

Udemy, Inc. (UDMY) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a...

November 2, 2023, 7:32 pm

Prothena (prta) beats q3 earnings and revenue estimates

Prothena (PRTA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of a...

November 2, 2023, 7:32 pm

Cambium (cmbm) reports q3 loss, tops revenue estimates

Cambium (CMBM) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of...

November 2, 2023, 6:47 pm

Cytokinetics (cytk) reports q3 loss, misses revenue estimates

Cytokinetics (CYTK) came out with a quarterly loss of $1.35 per share versus the Zacks Consensus Estima...

November 2, 2023, 6:47 pm

Cerus (cers) reports q3 loss, lags revenue estimates

Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a...

November 2, 2023, 6:47 pm

Ngm biopharmaceuticals (ngm) reports q3 loss, misses revenue estimates

NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.35 per share versus the Zacks Consens...

November 2, 2023, 6:47 pm


Search within

Pages Search Results: